Hemostasis, Bleeding and Transfusions Flashcards
Coagulation pathway
Extrinsic coagulation pathway:
Begins with thromboplastin
Interacts with factor VII to convert factor X to Xa
Intrinsic coagulation pathway:
Requires factors XII, XI, IX, and VIII to convert factor X to Xa
Common coagulation pathway:
Involves factor X, V, II (prothrombin), and I (fibrinogen)
Factor XIII (fibrin-stabilizing factor)
Bleeding may occur with deficiency of any factors except factor XII
Prothrombin Time
Measures ability of the blood to form stable thrombi
Evaluates factors VII, X, and V, prothrombin, and fibrinogen, and both extrinsic and common pathways
Most common use is monitoring Warfarin
PT is reported with international normalized ratio (INR)
Partial Thromboplastin Time
Evaluates adequacy of fibrinogen, prothrombin, factors V, VIII, IX, X, XI, XII, and intrinsic/common pathways
Most commonly used to evaluate unfractionated heparin therapy
Normal in patients with factor VII deficiency
Hemophilia A
Reduced Factor 8 Joints and intramuscular Only males Labs: Prolonged PTT Normal PT Normal platelet function
Von Willebrand Disease
Reduced Factor 8 and von Willebrand Activity
Treat with cryoprecipitate infusions and DDAVP
DIC
Intravascular coagulation and thrombosis that is diffuse instead of localized at the site of injury
Results in systemic deposition of platelet-fibrin microthrombi that causes diffuse tissue injury
Extensive endothelial damage to vascular wall
Hypotension
FFP
FFP is the platelet-poor plasma removed from whole blood
Does not contain RBC, leukocytes, or platelets
Indication for use: Lab evidence of coagulation factor deficiency with clinical bleeding, Need for invasive procedure
Metabolic derangements as a complicaiton from blood transfusion
Hypocalcemia
Hyper and Hypokalemia
hypothermia (transfuse fluids through a warmer)
Hemolytic reactions
Most caused by ABO-mismatched blood Present with; Hot or cold flushing Chest pain Low back pain Fever hypotension Stop transfusion and recheck blood